Skip to content

Investigation of skin sensitivity in Keratosis Pilaris

Investigation of skin sensitivity in Keratosis Pilaris

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097363
Enrollment
Unknown
Registered
2025-02-18
Start date
2024-01-20
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratosis Pilaris

Interventions

Keratosis Pilaris:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with keratosis pilaris in any anatomical site, male or female, no limit to age, under 18 years old need to be accompanied by parents. Other skin diseases such as atopic dermatitis, rosacea and other diseases need to be recorded, and later statistics and subgroup analysis.

Exclusion criteria

Exclusion criteria: 1 within 6 months of retinol system drug use, or within 2 weeks of internal and external prescription drug treatment (retinoic acid, antibiotics); 2 Received immunosuppressive therapy within 3 months before participating in the measurement; 3 Received systemic hormone therapy or phototherapy within 1 month before taking the measurement; 4 Pregnant or lactating women; 5 severe liver and kidney insufficiency; 6 Patients with chronic wasting diseases

Design outcomes

Primary

MeasureTime frame
10Sensitive Scale Questionnaire;Dermatology Life Quality Index;Lactic acid sting tes;Transepidermal water loss;Stratum corneum hydration;Red areas;

Countries

China

Contacts

Public ContactHua Wei

West China Hospital, Sichuan University

249082250@qq.com+86 181 2337 7561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026